Clinical Trials Logo
  1. Home
  2. Staphylococcal Infection
  3. NCT02284555

Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)

Staphylococcal Infection Clinical Trial

Official title:
A Single Centre, Open, Non-controlled Study in Healthy Subjects to Assess the Eradication of Nasal Carriage of Staphylococcus Aureus (SA) Following a Five Day Course of Mupirocin (Bactroban 2% Nasal Ointment) Using a Broth Enriched Culture Microbiological Assessment.

Clinical Trial Summary

This study will assess the nasal eradication of SA in healthy subjects following treatment with mupirocin 2% (Bactroban 2% Nasal Ointment) twice daily for 5 days, by means of a broth enriched culture microbial assay. The sensitivities of broth enrichment and plating assay methods will be compared. The safety and tolerability of Bactroban 2% Nasal Ointment will also be assessed.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02284555
Study type Interventional
Source Destiny Pharma Ltd
Contact
Status Completed
Phase Phase 4
Start date August 2014
Completion date November 2014
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT02899702 - Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children Phase 4
Completed NCT00770341 - A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002) Phase 3
Completed NCT00352612 - Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections Phase 4
Completed NCT00279864 - The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection N/A
Completed NCT00735839 - V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED) Phase 1
Completed NCT00814151 - MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial N/A
Completed NCT02812446 - Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development N/A
Completed NCT00846105 - Efficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA) N/A
Completed NCT01592214 - Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73 Phase 1
Completed NCT01827358 - Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants Phase 2
Completed NCT00729937 - Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA" Phase 2/Phase 3
Completed NCT00730028 - Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus Phase 2